Yun xiang Liang

Prof. Yun xiang Liang

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2015 in Carbohydrate Polymers
Verified
Journal Article
Closed access
YMYuxia Mei
Yuxia Mei
HZHai Zhu
Hai Zhu
QHQiming Hu
Qiming Hu
YLYangyang Liu
Yangyang Liu
SZShumiao Zhao
Shumiao Zhao
YLYun xiang Liang
Yun xiang Liang

1 June 2015 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
YMYu-Xia Mei
Yu-Xia Mei
XDXing-Yi Dai
Xing-Yi Dai
WYWei Yang
Wei Yang
XXXiong-Wei Xu
Xiong-Wei Xu
YLYun xiang Liang
Yun xiang Liang

1 February 2017 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
YWYunguang Wang
Yunguang Wang
BLBin Li
Bin Li
XZXuedan Zhang
Xuedan Zhang
NPNan Peng
Nan Peng
YMYuxia Mei
Yuxia Mei
YLYun xiang Liang
Yun xiang Liang

30 January 2019 in Nutrients
Verified
Journal Article
Open access
PDF file
YLYangyang Liu
Yangyang Liu
CWChaorui Wang
Chaorui Wang
JLJinshan Li
Jinshan Li
YMYuxia Mei
Yuxia Mei
YLYun xiang Liang
Yun xiang Liang
Hypoglycemic and hypolipidemic effects of P. linteus have been observed in numerous studies, but the underlying molecular mechanisms are unclear. In this study, we prepared P. linteus extract (PLE) from mycelia of solid-state culture, and evaluated its hypoglycemic and hypolipidemic effects in rat models of high-fat diet (HFD)-induced and low-dose streptozotocin (STZ)-induced type 2 diabetes. PLE treatment effectively reduced blood glucose levels, and improved insulin resistance and lipid and lipoprotein profiles. The hypoglycemic effect of PLE was based on inhibition of key hepatic gluconeogenesis enzymes (FBPase, G6Pase) expression and hepatic glycogen degradation, and consequent reduction of hepatic glucose production. PLE also: (i) enhanced expression of CPT1A and ACOX1 (key proteins involved in fatty acid β-oxidation) and low-density lipoprotein receptor (LDLR) in liver, thus promoting clearance of triglycerides and LDL-C; (ii) inhibited expression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) in liver, thus reducing cholesterol production; (iii) displayed strong hepatoprotective and renal protective effects. Our findings indicate that PLE has strong potential functional food application in adjuvant treatment of type 2 diabetes with dyslipidemia.

19 October 2020 in Antibiotics
Verified
Journal Article
Open access
PDF file
JZJIANG ZHENG
JIANG ZHENG
Junwei WeiJunwei Wei
Junwei Wei
YLYun xiang Liang
Yun xiang Liang
NPNan Peng
Nan Peng
YLYingjun Li
Yingjun Li
Antibiotic resistance is becoming the biggest threat to global health. At the same time, phage therapy is witnessing a return of interest. The therapeutic use of bacteriophages that infect and kill bacteria is a suitable strategy to combat antibiotic resistance. Furthermore, bacteriophages are increasingly used in combination with standard antibiotics against drug-resistant pathogens. Interestingly, we found that the engineered mycobacteriophage phAE159 and natural phage D29 cannot infect the Mycobacterium tuberculosis in the presence of kanamycin, hygromycin or streptomycin, but the phage infection was not affected in the presence of spectinomycin. Based on a series of studies and structural analysis of the above four aminoglycoside antibiotics, it could be speculated that the amino sugar group of aminoglycoside might selectively inhibit mycobacteriophage DNA replication. Our discovery that broad-spectrum antibiotics inhibit phage infection is of great value. This study will provide guidance for people to combine phage and antibiotics to treat M. tuberculosis.

24 July 2021 in Poultry Science
Verified
Journal Article
Open access
AZA.R. Zhang
A.R. Zhang
MWM. Wei
M. Wei
LYL. Yan
L. Yan
GZG.L. Zhou
G.L. Zhou
YLY. Li
Y. Li
YLYun xiang Liang
Yun xiang Liang
Solid-state fermentation has been used to improve the nutritive value of feed ingredients. In the present study, we investigated the effects of solid-state fermented wheat bran (FWB) on growth performance and apparent digestibility in broiler chickens. We measured the growth performance (ADFI, ADG, feed conversion, livability, and European performance efficiency factor) over 38 d in chicks fed a corn-soybean meal control diet (CON) or CON plus wet FWB (25 g/kg [T1]; 50 g/kg [T2]); or T1 plus 3 g/kg (T3); or T2 plus 6 g/kg (T4) soybean oil). The same diets were used to determine nutrient availability in chicks aged 20 d. Regression equations for AME and AMEn were obtained using 20-day-old chicks fed either the corn-soybean meal basal diet only or basal diet partially substituted with 50, 150, or 300 g/kg DM FWB. Diets containing 25 or 50 g/kg wet FBW did not affect the growth performance of broiler chickens, nor the apparent DM, energy, and nitrogen digestibility of the feeds, compared with the control diets (all P > 0.05). Further supplementation with oil did not improve the growth performance of broiler chickens compared with controls or chickens fed FBW. However, chickens fed diets containing soybean oil (T3 or T4) had lower (P = 0.005 and P = 0.040, respectively) apparent DM and energy digestibility than the control and FWB groups. The regression equations for AME and AMEn with the substitution of FWB produced values of 1,854.3 and 1,743.9 kcal/kg DM, respectively, and the equations were Y = 1854.3X + 52.7 (R2 = 0.971, n = 24, P < 0.001), and Y = 1743.9X + 44.6 (R2 = 0.978, n = 24, P < 0.001), respectively. Supplementation with wet FWB did not affect the growth performance of broiler chickens. Therefore, FWB is a suitable feed component for broilers.